Red Raspberry Leaf in Pregnancy and Labour

If you are reading this at 34 weeks with a box of pregnancy tea on the counter, here is the whole answer before the detail: no clear benefit has been demonstrated for raspberry leaf in labour, and the small amount of clinical work that exists is reassuring rather than conclusive on safety. It is not an induction method. The one randomized trial, in low-risk first-time mothers taking raspberry leaf tablets from 32 weeks, found no adverse effects for mother or baby, and it found no shortening of the first stage of labour.

That is an unsatisfying answer, and it is the true one. This page explains where it comes from: what the tradition claims, what the laboratory found (and why the laboratory findings contradict each other), what the Australian studies actually measured, what the systematic reviews concluded, and where the genuine cautions lie. It is written for the person drinking the tea, not for a journal club — but it does not round the numbers in the tea’s favour to be encouraging.


Table of Contents

  1. The Claim, Stated Precisely
  2. What “Uterine Tonic” Means, and Why It Resists Testing
  3. The Laboratory Contradiction: Relaxant and Stimulant
  4. The 1999 Retrospective Study
  5. The 2001 Randomized Double-Blind Trial
  6. The 2024 Prospective Observational Study
  7. What the Systematic Reviews Concluded
  8. It Is Not a Labour Induction Method
  9. Safety in Pregnancy: Known, Assumed, and Unknown
  10. Animal Data and the Offspring Question
  11. If You Are Going to Drink It Anyway
  12. Evidence Tiers at a Glance
  13. Key Research Papers
  14. Connections
  15. Featured Videos

The Claim, Stated Precisely

Vagueness is how weak claims survive, so it is worth writing the traditional claim out in the strongest specific form anyone actually makes it. Raspberry leaf, taken as a tea from roughly the eighth month of pregnancy, is said to:

  1. “Tone” the uterine muscle so that contractions in labour are better coordinated and more effective;
  2. shorten labour, particularly the pushing stage;
  3. reduce the need for intervention — fewer forceps, fewer ventouse deliveries, fewer caesareans;
  4. reduce bleeding after birth, on the theory that a well-toned uterus clamps down better;
  5. and, in the folk version that circulates online rather than in midwifery texts, bring labour on when a pregnancy has gone past its date.

Claim 5 has no support at all and is dealt with below. Claims 1 through 4 have been tested exactly once in a randomized trial, in one country, by one research group, in 192 women. Until 2024 the clinical evidence on raspberry leaf and labour rested on that single trial plus one earlier look-back study by the same team; a 2024 prospective observational study of 91 women, by different authors, has since been added (see below).

The tea remains very popular. A 2026 Australian survey of 561 women in pregnancy found that 68% had taken one or more herbal medicines during their pregnancy; raspberry leaf was the most common herb, used by 37%, and the most common reason given for using it was to make labour easier.

What “Uterine Tonic” Means, and Why It Resists Testing

“Tonic” is one of the oldest words in herbal medicine and one of the least testable. A tonic is not supposed to produce an event you can time; it is supposed to condition a tissue gradually so that when the tissue is called on, it performs better. Applied to the uterus, that means raspberry leaf is not claimed to cause a contraction — it is claimed to improve the quality of contractions that happen weeks later.

Notice what that does to the burden of proof. A herb that starts contractions can be tested in an afternoon. A herb that makes future contractions subtly better needs a trial that randomizes women months in advance, keeps them blinded, and then measures something as messy and multi-causal as the length of a labour — which depends on parity, fetal position, epidural use, maternal age, induction, obstetric practice on the day, and a dozen other things that swamp a small effect.

This matters for interpreting the evidence honestly in both directions. It is why the existing trial was probably too small to detect a modest real effect if one existed — and equally why a promising-looking secondary result in a trial of that size cannot be taken at face value. The uterus is also physiologically unusual: it changes receptor expression, gap-junction coupling and oxytocin sensitivity dramatically across late pregnancy, so a compound’s effect on non-pregnant tissue in a dish may bear no relation to its effect at term.

The Laboratory Contradiction: Relaxant and Stimulant

Evidence tier: preliminary (in vitro and animal).

The mechanism story usually names fragarine, an alkaloid found in Rubus and Fragaria (strawberry) leaves, and says it “tones” the uterus. Follow that claim back to its sources and it splits in half.

In 1941 The Lancet published Burn and Withell’s report of a principle in raspberry leaves that relaxed uterine muscle. In the same year the British Medical Journal carried Whitehouse’s description of fragarine as an inhibitor of uterine action. Both of those are relaxant findings — the opposite of “strengthens contractions.” Then in 1970 the British Journal of Pharmacology published work by Bamford and colleagues on raspberry leaf and uterine smooth muscle which found that the direction of the effect was not fixed: depending on the preparation and on whether the tissue was quiescent or already contracting, the extract could stimulate or could inhibit. A 2002 Phytotherapy Research study of Rubus idaeus leaf extract on guinea-pig ileum again found relaxant activity on smooth muscle.

So the pharmacological record supports the statement “raspberry leaf extracts affect smooth muscle in a dish.” It does not support “raspberry leaf tones the uterus.” The tradition resolved the contradiction by adopting a word — tonic — elastic enough to mean relaxation and stimulation simultaneously, whichever the situation seems to require. A drug that both relaxes and strengthens a muscle depending on need would be remarkable; the more ordinary explanation is that different extracts of a tannin-rich leaf, applied to different tissues in different states, produce different results, and that none of it was measured in a pregnant human uterus at term.

Two further caveats worth stating. First, these were extracts, often alcoholic or concentrated, applied directly to tissue — not a cup of infusion crossing a gut wall, surviving first-pass metabolism and reaching the myometrium. Second, the alkaloid content of raspberry leaf is low and variable, and fragarine has never been characterised pharmacologically the way a drug candidate would be. It is a name that carries more authority in herbal writing than it has earned in pharmacology.

The 1999 Retrospective Study

Evidence tier: observational, retrospective — hypothesis-generating only.

Parsons, Simpson and Ponton published “Raspberry leaf and its effect on labour: safety and efficacy” in the Australian College of Midwives Incorporated Journal in 1999. They looked back at the records of women who had given birth at Westmead Hospital in Australia between January and July 1998 and compared those who had taken raspberry leaf with those who had not — 108 mothers in all, 57 who had taken raspberry leaf products and 51 who had not. Their report suggested that the raspberry-leaf group tended to have shorter labours and fewer interventions, and it found no evidence of harm.

The design is the problem, and it is not a small one. Women were not assigned to raspberry leaf; they chose it. Women who choose a herbal pregnancy tea differ systematically from women who do not — in antenatal education, in planned place and mode of birth, in attitude to epidural and to intervention, often in parity and in who their care provider is. Any of those differences could produce a shorter recorded labour with fewer forceps without the tea doing anything whatsoever. This is the same confounding that made decades of observational nutrition findings evaporate in trials.

A retrospective study of this kind has one legitimate use: it justifies running a proper trial. To their credit, that is exactly what the same group did next.

The 2001 Randomized Double-Blind Trial

Evidence tier: randomized controlled trial — single, small, and the best evidence that exists.

Simpson, Parsons, Greenwood and Wade published “Raspberry leaf in pregnancy: its safety and efficacy in labor” in the Journal of Midwifery & Women’s Health in 2001. Low-risk women expecting their first baby were randomized in the last weeks of pregnancy — from around 32 weeks — to raspberry leaf tablets or to an identical placebo, taken twice daily until labour. Neither the women nor the staff knew which they were receiving. The trial enrolled 192 women at a large hospital in Sydney, and the dose was 2 × 1.2 g of raspberry leaf tablets per day.

The findings, as plainly as they can be put:

How much weight should the second and third points carry? Less than the internet gives them. They were secondary outcomes in a single trial of under 200 women. In a trial that size, with many outcomes measured, one or two differences reaching statistical significance by chance is expected rather than surprising. Second-stage duration in particular is highly sensitive to obstetric practice — when a clinician decides to intervene — and the forceps finding is not independent of it: if a labour is allowed to proceed a little longer, forceps are used a little less, and both numbers move together for reasons that have nothing to do with tea.

None of this means the herb does nothing. It means that after the only randomized trial ever conducted, the honest conclusion is that no clear benefit was demonstrated, with a hint on secondary measures that would need a trial several times larger to confirm or bury. That larger trial has never been run; the authors of the 2024 observational study described below still called a randomized controlled trial “urgently needed.”

The 2024 Prospective Observational Study

Evidence tier: observational, prospective — hypothesis-generating only.

Bowman, Taylor and Davis published “Raspberry leaf (Rubus idaeus) use in pregnancy: a prospective observational study” in BMC Complementary Medicine and Therapies in 2024. Women filled in questionnaires about their herbal use in pregnancy, and their birth outcomes were taken from the maternity service’s clinical database. Complete records were available for 91 women: 44 who used raspberry leaf and 47 who did not.

A smaller proportion of the raspberry-leaf users had their labour medically sped up (augmentation of labour), an epidural, an instrumental birth, a caesarean section or heavy bleeding after the birth (postpartum haemorrhage). A larger proportion had a vaginal birth, and all phases of labour were shorter. In the authors’ analysis, raspberry leaf use “was strongly predictive of women not having their labours medically augmented.”

The authors state the limits themselves: the results “cannot be relied on or generalised to the wider population of pregnant women,” and although no safety concerns were observed, this “should not be taken as evidence that raspberry leaf is safe.” As in the 1999 study, the women were not assigned to the herb. The authors conclude that a randomized controlled trial is urgently needed.

What the Systematic Reviews Concluded

Independent reviewers, working from wider sets of studies — 12 original publications in one review, 13 laboratory, animal and human studies published between 1941 and 2016 in another — reached the same verdict.

Holst, Haavik and Nordeng asked the question directly in the title of their 2009 paper in Complementary Therapies in Clinical Practice: “Raspberry leaf — should it be recommended to pregnant women?” Their answer was that the documentation is too limited to recommend it, and they noted that the herb’s popularity rests on tradition rather than on data.

Bowman, Taylor, Muggleton and Davis published a systematic integrative review, “Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy,” in BMC Complementary Medicine and Therapies in 2021. Their conclusion, in substance: the evidence is insufficient to support the claimed benefits, the safety data are limited but do not show a clear signal of harm, and better research is needed before raspberry leaf can be recommended or ruled out. The review also noted that one human study showed a clinically meaningful, though not statistically significant, reduction in the length of the second stage of labour and in augmentation of labour among women taking raspberry leaf. Broader reviews of herbal medicine in pregnancy — Dante and colleagues in Current Opinion in Obstetrics & Gynecology in 2014, and Muñoz Balbontín and colleagues in Obstetrics & Gynecology in 2019 — place raspberry leaf among herbs that are commonly used and poorly evidenced. Dante and colleagues found very few scientific data supporting raspberry, blue cohosh, castor oil and evening primrose oil for easing labour, and noted that these remedies have been associated with severe adverse events. Muñoz Balbontín and colleagues found oral raspberry leaf associated with caesarean delivery in the studies they reviewed (adjusted odds ratio 3.47, 95% CI 1.45–8.28), and concluded that herbal medicinal product use in pregnancy and after birth should be discouraged until robust evidence of safety is available.

It is worth appreciating what a consistent picture this is. Reviewers with no stake in the outcome, working a decade apart, all land on insufficient evidence. That is not a fashionable scepticism; it is what a limited body of studies, part of it 50 years old or older, supports.

It Is Not a Labour Induction Method

Evidence tier: not supported by any study.

This section exists because the belief is widespread and because acting on it can cause real harm.

Nothing in the literature shows raspberry leaf starts labour. It has never been tested as an induction agent, no trial has found it triggers contractions, and the pharmacology — which, remember, leans relaxant as often as stimulant — gives no reason to expect it would. Ripening a cervix and initiating labour is a coordinated hormonal cascade involving prostaglandins, oxytocin receptor upregulation and gap-junction formation. A dilute infusion of a tannin-rich leaf is not a plausible trigger for it.

The specific harms of believing otherwise:

If a pregnancy needs to be moved along, that is a clinical decision with monitored methods behind it. See Preterm Labor for why the timing of contractions matters so much.

Safety in Pregnancy: Known, Assumed, and Unknown

The fair summary is reassuring, not established. Millions of cups have been drunk over generations without an obvious pattern of disaster, and the randomized trial saw no harm to mothers or babies. That is meaningful. It is also not a safety database: fewer than 200 women in one trial cannot detect an uncommon harm, and traditional use is not surveillance — it records what people did, not what happened to them.

The specific points that matter, each with its actual basis:

Animal Data and the Offspring Question

Evidence tier: preliminary (animal).

One study deserves naming because it is the main reason a careful writer will not say raspberry leaf is simply safe. Johnson, Makaji, Ho, Xiong, Crankshaw and Holloway published “Effect of maternal raspberry leaf consumption in rats on pregnancy outcome and the fertility of the female offspring” in Reproductive Sciences in 2009 — a rat study looking not just at the pregnancy but at the reproductive development of the female pups. Pregnant Wistar rats were given raspberry leaf, an inactive vehicle, or one of two flavonoids found in the leaf, kaempferol or quercetin (the abstract gives 10 mg/kg per day), from confirmed mating until birth. Raspberry leaf use during pregnancy was associated with a longer pregnancy (increased gestation length) and with accelerated reproductive development in the female offspring. The 2009 review by Holst and colleagues noted that only this latest animal study indicates an increased risk for the unborn child, while adding that all the studies are small and cannot rule out negative effects on pregnancy outcome.

Rat studies translate to humans unreliably; doses are often far above what a person consumes, and rodent reproductive physiology is not human reproductive physiology. A rat finding on its own does not show that the same happens in women. What it does establish is that the question “does prenatal exposure affect the offspring later?” has been asked, has produced findings worth following up, and has never been followed up in humans. When somebody says raspberry leaf is “proven safe in pregnancy,” that is the gap they are talking over.

If You Are Going to Drink It Anyway

Plenty of readers will finish this page and still want the tea, a mild traditional drink with a long history of third-trimester use. The practical facts:

  1. Most users do not tell their midwife or doctor. In a 2009 survey of 578 pregnant women at a hospital antenatal clinic in the United Kingdom, 57.8% had used herbal remedies during pregnancy — raspberry leaf among the most common — and more than 75% of users had not told their doctor or midwife. The survey’s authors called on doctors and midwives to ask pregnant women about herbal remedies.
  2. Traditional practice starts it in the third trimester, from around 32 weeks; the 2001 trial also started at 32 weeks.
  3. There is no evidence-based dose to reach. More has not been shown to be better; the 2001 trial used tablets of 2 × 1.2 g per day, and the dosing page explains the ceiling.
  4. Capsules and tinctures are more concentrated than the tea, and differ from the tablets used in the one trial.
  5. Its tannins reduce iron absorption when the tea is taken with iron-rich meals or iron tablets.
  6. No particular effect on labour is established. Women in a 2026 Australian survey described the tea as part of their pregnancy “ritual” and as comforting. On labour itself, the only randomized trial found no shorter first stage, and a second stage shorter by a mean of 9.59 minutes.
  7. Regular contractions before 37 weeks, any bleeding, fluid loss, or reduced fetal movement are signs that maternity units treat as urgent, whatever tea is being taken.

Evidence Tiers at a Glance

Back to Table of Contents

Key Research Papers

Each entry names the paper and links its PubMed record (or DOI), so you can confirm for yourself that the description matches the paper.

  1. Simpson M, Parsons M, Greenwood J, Wade K. “Raspberry leaf in pregnancy: its safety and efficacy in labor.” Journal of Midwifery & Women’s Health, 2001;46(2):51-9 — the only randomized, double-blind, placebo-controlled trial. — PubMed PMID: 11370690
  2. Parsons M, Simpson M, Ponton T. “Raspberry leaf and its effect on labour: safety and efficacy.” Australian College of Midwives Incorporated Journal, 1999;12(3):20-5 — the retrospective study that preceded it. — PubMed PMID: 10754818
  3. Holst L, Haavik S, Nordeng H. “Raspberry leaf — should it be recommended to pregnant women?” Complementary Therapies in Clinical Practice, 2009;15(4):204-8 — concludes the documentation is too limited. — PubMed PMID: 19880082
  4. Bowman R, Taylor J, Muggleton S, Davis D. “Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy: a systematic integrative review.” BMC Complementary Medicine and Therapies, 2021;21(1):56. — PubMed PMID: 33563275
  5. Bowman RL, Taylor J, Davis DL. “Raspberry leaf (Rubus idaeus) use in pregnancy: a prospective observational study.” BMC Complementary Medicine and Therapies, 2024;24(1):169 — 91 women, 44 users and 47 non-users. — PubMed PMID: 38649906
  6. Bowman RL, Davis DL, Taylor J. “Beyond prescription medicine in pregnancy — raspberry leaf and other herbs in Australia.” BMC Complementary Medicine and Therapies, 2026;26(1):100 — survey of 561 women on herbal use in pregnancy. — PubMed PMID: 41668030
  7. Burn JH, Withell ER. “A principle in raspberry leaves which relaxes uterine muscle.” The Lancet, 1941;238(6149):1-3 — the relaxant finding at the root of the mechanism story. — doi:10.1016/S0140-6736(00)71348-1
  8. Whitehouse B. “Fragarine: an inhibitor of uterine action.” British Medical Journal, 1941;2(4210):370-1 — fragarine described as inhibitory, not tonic. — PubMed PMID: 20783856
  9. Bamford DS, Percival RC, Tothill AU. “Raspberry leaf tea: a new aspect to an old problem.” British Journal of Pharmacology, 1970;40(1):161P-162P — meeting abstract; effect direction depends on preparation and tissue state. — PubMed PMID: 5487014
  10. Rojas-Vera J, Patel AV, Dacke CG. “Relaxant activity of raspberry (Rubus idaeus) leaf extract in guinea-pig ileum in vitro.” Phytotherapy Research, 2002;16(7):665-8. — PubMed PMID: 12410549
  11. Johnson JR, Makaji E, Ho S, Xiong B, Crankshaw DJ, Holloway AC. “Effect of maternal raspberry leaf consumption in rats on pregnancy outcome and the fertility of the female offspring.” Reproductive Sciences, 2009;16(6):605-9. — PubMed PMID: 19276407
  12. Cheang KI, Nguyen TT, Karjane NW, Salley KE. “Raspberry leaf and hypoglycemia in gestational diabetes mellitus.” Obstetrics & Gynecology, 2016;128(6):1421-4 — single case report behind the diabetes caution. — PubMed PMID: 27824754
  13. Holst L, Wright D, Haavik S, Nordeng H. “The use and the user of herbal remedies during pregnancy.” The Journal of Alternative and Complementary Medicine, 2009;15(7):787-92 — how common the practice is, and how rarely it is disclosed. — PubMed PMID: 19538045
  14. Muñoz Balbontín Y, Stewart D, Shetty A, Fitton CA, McLay JS. “Herbal medicinal product use during pregnancy and the postnatal period: a systematic review.” Obstetrics & Gynecology, 2019;133(5):920-32. — PubMed PMID: 30969204
  15. Dante G, Bellei G, Neri I, Facchinetti F. “Herbal therapies in pregnancy: what works?” Current Opinion in Obstetrics & Gynecology, 2014;26(2):83-91. — PubMed PMID: 24535321
  16. Cochrane reviews of methods used to induce labour — useful context for what an intervention with real evidence looks like. — Search PubMed

Back to Table of Contents

Back to Table of Contents

Connections


This page is information, not antenatal advice. It describes published research about a traditional herbal tea; it is not a treatment recommendation, not a dosing instruction from a clinician, and not a substitute for care from your midwife, obstetrician or physician — who knows your pregnancy, and this page does not. Raspberry leaf has never been shown to bring on labour. The one randomized trial enrolled only low-risk first-time mothers, so there are no trial data for high-risk pregnancies, a history of preterm labour or a planned caesarean; in a woman taking insulin for gestational diabetes, a case report describes low blood sugar that needed a lower insulin dose. Contractions before 37 weeks, bleeding, fluid loss, severe headache or visual changes, or reduced fetal movement are signs that maternity units treat as urgent.

Back to Table of Contents